| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| Urinary Collection Device Market Size 2024 |
USD 2812 Million |
| Urinary Collection Device Market, CAGR |
5.2% |
| Urinary Collection Device Market Size 2032 |
USD 4218.33 Million |
Market Overview:
The Urinary Collection Device Market size was valued at USD 2812 million in 2024 and is anticipated to reach USD 4218.33 million by 2032, at a CAGR of 5.2% during the forecast period (2024-2032).
One of the key drivers of market growth is the rising incidence of urological disorders globally. The increasing prevalence of conditions such as benign prostatic hyperplasia (BPH), neurogenic bladder dysfunction, and post-surgical urinary retention has led to a higher demand for urinary collection devices. According to the World Health Organization (WHO), over 200 million people worldwide suffer from some form of urinary incontinence, underscoring the growing need for effective management solutions. The market is also benefiting from technological innovations that improve patient comfort and reduce the risk of infections, including antimicrobial-coated catheters and self-sealing urine bags. Manufacturers are increasingly focusing on single-use and latex-free options to enhance patient safety. Additionally, the growing preference for home healthcare solutions and ambulatory surgical centers is fueling demand for portable and easy-to-use devices. Supportive government initiatives and insurance reimbursement policies are also encouraging greater adoption, particularly in developed markets.
Regionally, North America dominates the urinary collection device market, attributed to a well-established healthcare infrastructure, high awareness of urinary disorders, and increased adoption of advanced medical devices. The U.S. accounts for the largest market share, with extensive investments in urological research and an increasing number of elderly patients requiring long-term catheterization. Europe follows closely, driven by an aging population and strong government healthcare support. Countries such as Germany, France, and the UK are seeing significant product advancements due to favorable reimbursement frameworks and higher healthcare spending. The Asia-Pacific region is witnessing the fastest growth, fueled by rising healthcare expenditures, improving medical infrastructure, and increasing awareness of incontinence management solutions. In China and India, expanding geriatric populations and increasing disposable incomes are contributing to the rising demand for urinary collection devices. Meanwhile, Latin America and the Middle East & Africa are experiencing moderate growth, with increasing healthcare investments and expanding access to urology care services.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research!
Download Sample
Market Insights:
- The urinary collection device market was valued at USD 2812 million in 2024 and is projected to reach USD 4218.33 million by 2032, growing at a CAGR of 5.2% during the forecast period.
- The increasing prevalence of urological disorders, including benign prostatic hyperplasia (BPH), neurogenic bladder dysfunction, and post-surgical urinary retention, is driving the demand for urinary collection devices globally.
- Technological advancements, such as antimicrobial-coated catheters, self-sealing urine bags, and smart monitoring systems, are enhancing patient safety, reducing infections, and improving overall device efficiency.
- The home healthcare sector is expanding, increasing demand for portable and easy-to-use urinary collection solutions, particularly among elderly patients and individuals managing chronic conditions.
- Government support and insurance reimbursement policies in developed markets are improving patient access to urinary collection devices, fueling market growth.
- North America dominates the market with a 39% share, followed by Europe at 30%, while Asia-Pacific is the fastest-growing region, holding a 21% share, driven by healthcare infrastructure expansion and rising disposable incomes.
- The market faces challenges such as infection risks, stringent regulatory requirements, and high costs, but continued innovation and healthcare investments are expected to drive long-term growth.
Market Drivers:
Rising Prevalence of Urological Disorders:
The increasing incidence of urological conditions such as benign prostatic hyperplasia (BPH), neurogenic bladder dysfunction, urinary incontinence, and post-surgical urinary retention is a major driver of the urinary collection device market. For instance, regarding urological disorders, Table 2 from a study on the prevalence and distribution of urological disorders (n=200) found that Benign Prostatic Hyperplasia and Prostate Cancer had lower p-values and higher odds ratios, suggesting more substantial associations with the disorders. According to the World Health Organization (WHO), over 200 million people globally suffer from some form of urinary incontinence, highlighting the urgent need for effective management solutions. The growing geriatric population, which is more susceptible to bladder dysfunction and chronic kidney diseases, is further increasing the demand for urinary collection devices, particularly catheters and urine drainage bags.
Technological Advancements in Urinary Collection Devices:
Innovations in material science and device design are significantly improving the efficiency and safety of urinary collection solutions. For instance, Merz Pharmaceuticals, a Germany-based company, saw overall licensing income during the patented period. The introduction of antimicrobial-coated catheters, self-sealing urine bags, and non-invasive collection devices has enhanced patient comfort while minimizing the risk of urinary tract infections (UTIs). Additionally, manufacturers are focusing on single-use and latex-free products to reduce allergic reactions and cross-contamination risks. Digital health integration, including sensor-equipped urine bags and smart monitoring systems, is further driving market expansion by enabling real-time tracking of urine output and infection prevention.
Expanding Home Healthcare and Ambulatory Care Services:
The shift toward home-based healthcare and ambulatory surgical centers is fueling demand for portable and easy-to-use urinary collection devices. For instance, a study published by the American Urological Association indicated that 39.0% of neurogenic bladder patients had a urology visit during a one-year follow-up period, highlighting the significant healthcare engagement among this population. Patients recovering from surgeries or managing chronic conditions prefer discreet and comfortable solutions that offer greater mobility. The expansion of telehealth services has also supported the home healthcare trend, allowing physicians to remotely monitor patients and recommend suitable urinary management products. This growing preference for outpatient care is reducing hospital stays, increasing the adoption of self-administered urinary collection devices, and driving market growth.
Government Support and Insurance Reimbursement Policies:
Favorable government initiatives and expanding insurance coverage for urological treatments are encouraging the adoption of urinary collection devices, particularly in developed markets. For instance, as a leading global specialty generic company, Sun Pharma puts patients at the heart of everything they do. In regions such as North America and Europe, reimbursement policies cover catheterization procedures, making these devices more accessible to patients. Additionally, regulatory agencies are implementing stricter quality standards for urinary collection devices, ensuring higher safety and reliability. Emerging economies are also witnessing increased healthcare investments aimed at improving access to essential urological care, further supporting market expansion.
Market Trends:
Adoption of Antimicrobial and Biocompatible Materials:
The market is witnessing a growing preference for urinary collection devices made from antimicrobial and biocompatible materials. Manufacturers are integrating silver-coated and hydrophilic catheters that reduce the risk of urinary tract infections (UTIs) and enhance patient safety. For instance, catheter surfaces displaying both hydrophobic and hydrophilic properties attract a wide variety of CAUTI pathogens. These innovations are particularly beneficial for individuals requiring long-term catheterization, as they help minimize bacterial adhesion and improve overall hygiene. The shift toward latex-free and hypoallergenic materials is also gaining traction, catering to patients with latex allergies and sensitivities.
Integration of Smart Monitoring Systems:
Advancements in digital health are driving the adoption of sensor-based urinary collection devices that offer real-time monitoring of urine output and infection risks. These smart solutions provide healthcare professionals with critical data, allowing for early detection of complications such as dehydration or kidney dysfunction. Remote monitoring capabilities are particularly beneficial for home healthcare patients, reducing the need for frequent hospital visits while ensuring continuous medical supervision. For instance, PreAnalytiX GmbH launched the PAXgene Urine Liquid Biopsy Set in September 2024 to enable the analytically reliable analysis of cfDNA from urine. The increasing use of IoT-enabled urine bags and catheter systems is further streamlining patient management and improving clinical outcomes.
Rising Demand for Home-Based and Portable Solutions:
The demand for portable urinary collection devices is increasing due to the expansion of home healthcare and ambulatory care services. Patients managing chronic conditions or post-surgical recovery prefer discreet and easy-to-use solutions that allow for greater mobility. For instance, the PureWick Female External Urinary Catheter allows for non-invasive urine output management for female patients. The rise of telehealth and virtual consultations is also supporting this trend, as healthcare providers can remotely assess patients and recommend suitable devices. The availability of compact, lightweight, and user-friendly urinary drainage systems is enhancing patient convenience and driving market adoption.
Regulatory Developments and Reimbursement Support:
Government regulations and insurance policies are playing a crucial role in shaping the urinary collection device market. Stricter quality standards are being enforced to ensure the safety and effectiveness of medical devices, leading to increased product innovation and compliance. For instance, operations carried out by the European Association of Urology Nurses (EAUN) in various countries are based on guidelines set forth by many governments in Europe. In developed markets, favorable reimbursement policies are improving patient access to high-quality urinary collection solutions. Meanwhile, emerging economies are witnessing greater healthcare investments, expanding the availability of essential urology products in hospitals and home care settings. These regulatory and financial factors are contributing to market growth and ensuring broader adoption of advanced urinary collection devices.
Market Challenges Analysis:
Risk of Infections and Complications:
One of the primary challenges in the urinary collection device market is the high risk of infections associated with prolonged catheter use. Catheter-associated urinary tract infections (CAUTIs) remain a significant concern in both hospital and home care settings, leading to increased healthcare costs and complications for patients. Despite advancements in antimicrobial coatings and infection-resistant materials, improper usage, inadequate hygiene, and extended catheterization periods continue to contribute to infection risks. Studies indicate that up to 80% of hospital-acquired UTIs are linked to indwelling catheters, emphasizing the need for better infection control protocols. Additionally, urinary leakage, discomfort, and device-related complications often lead to poor patient compliance, limiting the widespread adoption of certain collection systems. The World Health Organization (WHO) reports that CAUTIs increase hospital stays by an average of 2–4 days, placing a greater burden on healthcare facilities. Without proper infection control measures and patient education, the risk of antibiotic-resistant infections may further complicate treatment and patient recovery.
Regulatory Hurdles and Cost Constraints:
Stringent regulatory requirements for medical device approval pose a challenge for manufacturers, especially in regions with complex compliance frameworks. Regulatory bodies such as the FDA, EMA, and other national health authorities mandate rigorous clinical testing and safety evaluations, which can extend product development timelines and increase costs. Additionally, the high price of advanced urinary collection devices, including sensor-based and antimicrobial-coated catheters, restricts access for patients in low-income and underdeveloped regions. Reports suggest that the average cost of treating a CAUTI-related complication can be up to $1,000 per patient, further straining healthcare budgets. In countries with limited healthcare funding, the lack of reimbursement for advanced urinary collection products makes them unaffordable for many patients. The high cost of research and development for innovative urinary collection solutions also limits the entry of smaller manufacturers, restricting competition and slowing market growth. Addressing these challenges requires ongoing innovation, cost-effective manufacturing, and policy reforms to improve accessibility and affordability.
Market Opportunities:
The urinary collection device market presents significant opportunities driven by the increasing prevalence of urological disorders and the growing aging population. The rising incidence of conditions such as urinary incontinence, bladder dysfunction, and post-surgical urinary retention is creating a sustained demand for advanced collection devices. Innovations in product design, including antimicrobial-coated catheters, self-sealing urine bags, and non-invasive collection systems, are expected to enhance patient safety and comfort. Additionally, the expansion of home healthcare and ambulatory surgical centers is opening new growth avenues, as more patients seek portable and user-friendly urinary management solutions. The increasing adoption of telehealth and remote monitoring technologies further supports market expansion, allowing healthcare professionals to provide personalized device recommendations and improve patient outcomes.
Emerging markets in Asia-Pacific, Latin America, and the Middle East & Africa offer lucrative opportunities due to rising healthcare expenditures and improving medical infrastructure. Governments in these regions are actively investing in healthcare reforms, increasing access to essential urological care products. Moreover, the introduction of favorable reimbursement policies in developed markets is expected to drive higher adoption of premium urinary collection devices. The growing focus on sustainable and biodegradable medical products is also creating opportunities for manufacturers to develop eco-friendly alternatives. Companies that prioritize cost-effective production, regulatory compliance, and patient-centric innovation will gain a competitive edge in this evolving market landscape. Expanding strategic partnerships with healthcare institutions and research organizations will further accelerate technological advancements and market penetration.
Market Segmentation Analysis:
By Product
The urinary collection device market includes urinary catheters, urine drainage bags, external collection devices, and accessories. Urinary catheters dominate this segment due to their widespread use in hospitals, long-term care facilities, and home healthcare settings. Drainage bags are commonly used for post-surgical recovery and chronic bladder dysfunction management, ensuring efficient urine collection and disposal. External collection devices provide non-invasive solutions for patients with mild incontinence, offering greater comfort and reduced risk of infections compared to traditional catheters.
By Material
Urinary collection devices are primarily manufactured using latex, silicone, and PVC. Silicone-based products are gaining traction due to their biocompatibility, flexibility, and reduced risk of allergic reactions compared to latex alternatives. The shift toward antimicrobial-coated materials is improving infection control, while biodegradable materials are being explored to enhance sustainability in medical waste management.
By Gender
The market is divided into male and female urinary collection devices, each designed to meet specific anatomical and comfort requirements. Male-specific external catheters and sheath systems are widely used for long-term urinary management, while female urinary devices are being developed with ergonomic and discreet designs to enhance usability and patient convenience.
Segmentations:
By Product:
- Urinary Catheter
- Indwelling Catheter
- Foley Catheter
- Suprapubic Catheter
- Intermittent Catheter
- External Catheter
- Urine Bags
- Urinary Leg Bags
- Urinary Drainage Bags
- Urinary Belly Bags
- Urine Sample System
- Urine Sample Container
- Urine Sample Tube
- Urine Sample Bottle
- Accessories
By Material:
- Silicone
- Rubber
- Latex
- Others
By Gender:
By End User:
- Hospitals
- Homecare Settings
- Clinics
- Others
By Region:
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Regional Analysis:
North America
North America holds a market share of 39%, making it the largest regional market for urinary collection devices. The dominance of this region is driven by a well-established healthcare infrastructure, high awareness of urinary disorders, and the presence of key market players. The rising prevalence of urinary incontinence, particularly among the aging population, has increased the demand for advanced urinary collection solutions. The United States leads the regional market, supported by high healthcare spending and favorable reimbursement policies that ensure better patient access to high-quality devices. The growing emphasis on infection prevention has further fueled the adoption of antimicrobial-coated catheters and self-sealing urine bags. Additionally, technological advancements, including smart monitoring systems integrated with IoT, are gaining traction in hospitals and home healthcare settings.
Europe
Europe accounts for a market share of 30%, making it the second-largest regional market for urinary collection devices. The increasing geriatric population, combined with a high prevalence of urinary disorders such as overactive bladder and neurogenic bladder dysfunction, is driving demand for innovative collection solutions. Countries like Germany, France, and the United Kingdom are leading contributors due to strong government healthcare support and extensive investments in medical research. The widespread adoption of latex-free and biocompatible urinary devices is further supporting market growth, as regulatory bodies enforce stricter quality and safety standards. Additionally, the expansion of home healthcare services and long-term care facilities across Europe has increased demand for portable and user-friendly urinary collection products, particularly among elderly patients and individuals with chronic illnesses.
Asia-Pacific
Asia-Pacific holds a market share of 21%, positioning it as the fastest-growing region in the urinary collection device market. The rapid expansion of healthcare infrastructure, rising disposable incomes, and increasing awareness of urological health are key drivers of market growth. China and India are at the forefront of this expansion, with growing geriatric populations and higher incidences of urinary incontinence and kidney-related diseases. The demand for cost-effective and disposable urinary collection products is rising as hospitals and clinics work to enhance infection control measures. Additionally, government initiatives to improve healthcare access and expand insurance coverage are increasing the adoption of urinary management solutions. As telehealth services become more prevalent, the market is expected to see higher demand for home-use urinary collection devices, particularly in rural and semi-urban areas.
Key Player Analysis:
- Braun Melsungen AG
- Medline Industries, Inc.
- Teleflex Incorporated
- Coloplast
- Hollister Incorporated
- Amsino International, Inc.
- Boston Scientific Corporation
- Becton, Dickinson, and Company (BD)
- Wihuri Packaging Oy
- R. Brad
Competitive Analysis:
The urinary collection device market is characterized by intense competition, with several global and regional players focusing on innovation, product differentiation, and regulatory compliance. Leading manufacturers are investing in research and development to introduce advanced solutions such as antimicrobial-coated catheters, biodegradable urine bags, and sensor-based monitoring systems. For instance, Hollister Incorporated has developed innovative urine collection systems that enhance user comfort and reduce the risk of infection. Companies are also expanding their product portfolios to cater to the growing demand for home healthcare and minimally invasive urinary collection devices. Market players are strengthening their distribution networks through partnerships with hospitals, clinics, and online healthcare platforms. Stringent regulatory requirements present challenges, but companies with strong compliance capabilities gain a competitive advantage. Price competition is significant, particularly in emerging markets, where cost-effective solutions are in high demand. The increasing adoption of telehealth and remote monitoring technologies is also influencing competitive strategies, with firms focusing on digital integration to enhance patient care and convenience.
Recent Developments:
- In March 2024, Hollister Incorporated received a patent for a urinary catheter assembly featuring a moisture control layer made of wax over a hydrophilic material. This innovation aims to enhance patient comfort and protect the catheter from contaminants, allowing selective moisture ingress and egress during use.
- In April 2024, Medline and Consure Medical announced an exclusive agreement for Medline to distribute the QiVi® MEC male external urine management device. This device helps protect against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD).
- In September 2024, Medline introduced the FitRight® CONNECT™ Wetness Sensing System. This system combines briefs and a sensor pod to provide real-time alerts and data on residents’ incontinence episodes and voiding patterns to caregivers at skilled nursing homes. The solution aims to keep patient’s dryer for longer.
- In April 2024, Medline added the QiVi MEC male external urine management device to its catheter portfolio.
Market Concentration & Characteristics:
The urinary collection device market is moderately concentrated, with a mix of established global players and regional manufacturers competing to meet the rising demand for advanced urinary management solutions. Large multinational companies dominate the market with extensive product portfolios, strong distribution networks, and continuous investment in research and development. The industry is characterized by a strong focus on innovation, with manufacturers developing antimicrobial-coated catheters, self-sealing urine bags, and biocompatible materials to enhance patient safety and comfort. Regulatory compliance plays a crucial role, as stringent healthcare standards drive product quality and safety improvements. Additionally, the market is witnessing increased adoption of home-use urinary collection devices, fueled by the expansion of telehealth services and ambulatory care. Price sensitivity remains a key factor, particularly in emerging markets, where the demand for cost-effective and disposable solutions is driving competitive pricing strategies and localized manufacturing efforts.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Report Coverage:
The research report offers an in-depth analysis based on Product, Material, Gender, End-User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- The demand for urinary collection devices will continue to rise due to the increasing prevalence of urological disorders, particularly among the aging population and individuals with chronic conditions.
- Advancements in antimicrobial coatings and biocompatible materials will improve patient safety by reducing the risk of catheter-associated urinary tract infections (CAUTIs) and other complications.
- The growing preference for home healthcare and self-administered urinary management solutions will drive innovation in portable, discreet, and easy-to-use devices.
- The integration of sensor-based and IoT-enabled urinary collection devices will enhance real-time monitoring, allowing healthcare providers to track patient conditions remotely.
- Expanding healthcare infrastructure in emerging economies will increase accessibility to high-quality urinary collection products, improving patient outcomes in underserved regions.
- Regulatory compliance will remain a critical factor, prompting manufacturers to invest in product quality, safety standards, and clinical testing to meet stringent guidelines.
- Telehealth and digital healthcare solutions will further drive the adoption of smart urinary collection devices, enabling remote consultations and better patient monitoring.
- The shift toward sustainable and eco-friendly medical products will encourage the development of biodegradable and recyclable urinary collection solutions.
- Strategic collaborations between healthcare institutions and device manufacturers will accelerate innovation and market expansion.
- Increasing awareness and reimbursement policies in developed and developing regions will support the adoption of advanced urinary collection devices across diverse healthcare settings.
